ESR1 and breast carcinoma: In addition, given that the ERα expression status is strongly linked to breast cancer subtypes, RNF208 may be useful as a prognostic marker in breast cancers, and modulation of RNF208 in an ERα-dependent manner may be a therapeutic intervention against metastatic breast cancers.